Q3 2025 Holdings
Filed 2025-11-14 | 12 holdings | $222.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kestra Med Technologies Ltd(KMTS) | Common Stock | G52441105 | $39.1M | 1,645,893 | 17.6% |
| Beta Bionics Inc.(BBNX) | Common Stock | 08659B102 | $38.2M | 1,920,125 | 17.2% |
| BridgeBio Oncology Therapeutics Inc.(BBOT) | Common Stock | 107924102 | $38.1M | 3,289,661 | 17.1% |
| Bicara Therapeutics Inc.(BCAX) | Common Stock | 055477103 | $34.8M | 2,204,650 | 15.7% |
| Nuvation Bio(NUVB) | Common Stock Class A | 67080N101 | $32.7M | 8,831,089 | 14.7% |
| Upstream Bio Inc.(UPB) | Common Stock | 91678A107 | $25.5M | 1,356,293 | 11.5% |
| ImageneBio, Inc.(IMA) | Common Stock | 45175G207 | $3.7M | 455,361 | 1.7% |
| enGene Holdings Inc.(ENGN) | Common Stock | 29286M105 | $3.6M | 526,357 | 1.6% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $3.0M | 843,750 | 1.3% |
| Alumis Inc.(ALMS) | Common Stock | 022307102 | $2.6M | 653,223 | 1.2% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $1.0M | 248,672 | 0.5% |
| enGene Holdings Inc.(ENGNW) | Warrant | 29286M113 | $63.4K | 89,702 | 0.0% |